Literature DB >> 6434053

Intragastric bacterial activity and nitrosation before, during, and after treatment with omeprazole.

B K Sharma, I A Santana, E C Wood, R P Walt, M Pereira, P Noone, P L Smith, C L Walters, R E Pounder.   

Abstract

Ten healthy volunteers were studied before, during, and after treatment with omeprazole 30 mg daily for two weeks. On the 14th night mean nocturnal (2100-0700) intragastric acidity was significantly decreased by 75% (p less than 0.001). At 0700, 22 hours after the last dose of omeprazole, there were significant increases in the bacterial count and the nitrite and N-nitrosamine concentrations in the gastric juice (p less than 0.001). Three days later these changes had resolved. Short term treatment of healthy volunteers with omeprazole is associated with a short lived increase in the gastric bacterial flora, with endogenous production of N-nitroso compounds.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6434053      PMCID: PMC1442819          DOI: 10.1136/bmj.289.6447.717

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  15 in total

1.  Influence of gastric pH on gastric and jejunal flora.

Authors:  J D Gray; M Shiner
Journal:  Gut       Date:  1967-12       Impact factor: 23.059

2.  Pathogenesis of gastric cancer in pernicious anaemia.

Authors:  W S Ruddell; E S Bone; M J Hill; C L Walters
Journal:  Lancet       Date:  1978-03-11       Impact factor: 79.321

3.  Determination of a non-volatile N-nitrosamine on a food matrix.

Authors:  C L Walters; M J Downes; M W Edwards; P L Smith
Journal:  Analyst       Date:  1978-11       Impact factor: 4.616

4.  Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity.

Authors:  B K Sharma; R P Walt; R E Pounder; M D Gomes; E C Wood; L H Logan
Journal:  Gut       Date:  1984-09       Impact factor: 23.059

5.  Intragastric acidity, bacteria, nitrite, and N-nitroso compounds before, during, and after cimetidine treatment.

Authors:  G J Milton-Thompson; N F Lightfoot; Z Ahmet; R H Hunt; J Barnard; P M Bavin; R W Brimblecombe; D W Darkin; P J Moore; N Viney
Journal:  Lancet       Date:  1982-05-15       Impact factor: 79.321

6.  Effect of cimetidine on gastric juice N-nitrosamine concentration.

Authors:  P I Reed; P L Smith; K Haines; F R House; C L Walters
Journal:  Lancet       Date:  1981-09-12       Impact factor: 79.321

7.  Gastric juice N-nitrosamines in health and gastroduodenal disease.

Authors:  P I Reed; P L Smith; K Haines; F R House; C L Walters
Journal:  Lancet       Date:  1981-09-12       Impact factor: 79.321

8.  Intragastric nitrites, nitrosamines, and bacterial overgrowth during cimetidine treatment.

Authors:  R W Stockbrugger; P B Cotton; N Eugenides; B A Bartholomew; M J Hill; C L Walters
Journal:  Gut       Date:  1982-12       Impact factor: 23.059

9.  Comparison of the effects of ranitidine, cimetidine and placebo on the 24 hour intragastric acidity and nocturnal acid secretion in patients with duodenal ulcer.

Authors:  R P Walt; P J Male; J Rawlings; R H Hunt; G J Milton-Thompson; J J Misiewicz
Journal:  Gut       Date:  1981-01       Impact factor: 23.059

10.  Gastric bacteria, nitrate, nitrite and nitrosamines in patients with pernicious anaemia and in patients treated with cimetidine.

Authors:  B A Bartholomew; M J Hill; M J Hudson; W S Ruddell; C L Walters
Journal:  IARC Sci Publ       Date:  1980
View more
  49 in total

1.  Omeprazole: gastrin and gastric data.

Authors:  K G Wormsley
Journal:  Dig Dis Sci       Date:  1991-08       Impact factor: 3.199

2.  Effect of nizatidine 300 mg at night and omeprazole 20 mg in the morning on 24-hour intragastric pH and bacterial overgrowth in patients with acute duodenal ulcer.

Authors:  R J Brummer; R W Stockbrügger
Journal:  Dig Dis Sci       Date:  1996-10       Impact factor: 3.199

3.  Some possible pathological consequences of peptic ulcer therapy.

Authors:  D Poynter
Journal:  Gut       Date:  1990-02       Impact factor: 23.059

Review 4.  Helicobacter pylori in human health and disease: Mechanisms for local gastric and systemic effects.

Authors:  Denisse Bravo; Anilei Hoare; Cristopher Soto; Manuel A Valenzuela; Andrew Fg Quest
Journal:  World J Gastroenterol       Date:  2018-07-28       Impact factor: 5.742

5.  Effects of one year's treatment with ranitidine and of truncal vagotomy on gastric contents.

Authors:  J M Thomas; J J Misiewicz; A R Cook; M J Hill; P L Smith; C L Walters; J K Forster; L E Martin; D F Woodings
Journal:  Gut       Date:  1987-06       Impact factor: 23.059

Review 6.  Participation of microbiota in the development of gastric cancer.

Authors:  Li-Li Wang; Xin-Juan Yu; Shu-Hui Zhan; Sheng-Jiao Jia; Zi-Bin Tian; Quan-Jiang Dong
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

7.  Duodenal bacterial overgrowth during treatment in outpatients with omeprazole.

Authors:  M Fried; H Siegrist; R Frei; F Froehlich; P Duroux; J Thorens; A Blum; J Bille; J J Gonvers; K Gyr
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

Review 8.  Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.

Authors:  S P Clissold; D M Campoli-Richards
Journal:  Drugs       Date:  1986-07       Impact factor: 9.546

9.  Use of cimetidine and other peptic ulcer drugs in Denmark 1977-1990 with analysis of the risk of gastric cancer among cimetidine users.

Authors:  H Møller; A Nissen; J Mosbech
Journal:  Gut       Date:  1992-09       Impact factor: 23.059

10.  Effect of omeprazole on intragastric bacterial counts, nitrates, nitrites, and N-nitroso compounds.

Authors:  E Verdu; F Viani; D Armstrong; R Fraser; H H Siegrist; B Pignatelli; J P Idström; C Cederberg; A L Blum; M Fried
Journal:  Gut       Date:  1994-04       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.